Tytuł pozycji:
THREE PHASE 1/2, OPEN‐LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)‐BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)
-
Tytuł:
-
THREE PHASE 1/2, OPEN‐LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)‐BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)
-
Autorzy:
-
Morschhauser, F.
Nowakowski, G. S.
Cartron, G.
Kesanakurthy, V.
Gkasiamis, A.
Patah, P.
Delarue, R.
Wang, T.
Li, J.
Xian, D.
Fox, C. P.
Martin, P.
-
Źródło:
-
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
-